Evidence map›Paper›PMID 35328420›Full record

ArticleInternational journal of molecular sciences2022

Effects of Ultra-Short Pulsed Electric Field Exposure on Glioblastoma Cells.

Arianna Casciati, Mirella Tanori, Isabella Gianlorenzi, Elena Rampazzo, Luca Persano, Giampietro Viola, Alice Cani, Silvia Bresolin, Carmela Marino, Mariateresa Mancuso and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. In Vitro Imaging and Molecular Characterization of CaInternational journal of molecular sciences · 2023
    Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Arianna CasciatiItalian National Agency for Energy New Technologies and Sustainable Economic Development (ENEA), Division of Health Protection Technologies, Via Anguillarese 301, 00123 Rome, Italy.ORCID 0000-0003-2487-3060
Mirella TanoriItalian National Agency for Energy New Technologies and Sustainable Economic Development (ENEA), Division of Health Protection Technologies, Via Anguillarese 301, 00123 Rome, Italy.
Isabella GianlorenziDepartment of Ecological and Biological Sciences, University of Tuscia, Largo dell'Università, snc, 01100 Viterbo, Italy.
Elena RampazzoDepartment of Women's and Children's Health (SDB), University of Padova, via Giustiniani 3, 35128 Padova, Italy.
Luca PersanoDepartment of Women's and Children's Health (SDB), University of Padova, via Giustiniani 3, 35128 Padova, Italy.ORCID 0000-0002-0050-3666
Giampietro ViolaDepartment of Women's and Children's Health (SDB), University of Padova, via Giustiniani 3, 35128 Padova, Italy.ORCID 0000-0001-9329-165X
Alice CaniDepartment of Women's and Children's Health (SDB), University of Padova, via Giustiniani 3, 35128 Padova, Italy.ORCID 0000-0001-8467-2426
Silvia BresolinDepartment of Women's and Children's Health (SDB), University of Padova, via Giustiniani 3, 35128 Padova, Italy.
Carmela MarinoItalian National Agency for Energy New Technologies and Sustainable Economic Development (ENEA), Division of Health Protection Technologies, Via Anguillarese 301, 00123 Rome, Italy.
Mariateresa MancusoItalian National Agency for Energy New Technologies and Sustainable Economic Development (ENEA), Division of Health Protection Technologies, Via Anguillarese 301, 00123 Rome, Italy.ORCID 0000-0002-0912-9287
Caterina MerlaItalian National Agency for Energy New Technologies and Sustainable Economic Development (ENEA), Division of Health Protection Technologies, Via Anguillarese 301, 00123 Rome, Italy.ORCID 0000-0001-8612-9566
National Agency for New Technologies, Energy and Sustainable Economic Development · ITUniversity of Padua · ITUniversità degli Studi della Tuscia · IT

Funding

Fondazione Cassa di Risparmio di Padova e Rovigo 20/16FCRItalian Association for Cancer Research 20314SUMCASTEC 737164
6 · The paper itself

Abstract

Glioblastoma multiforme (GBM) is the most common brain cancer in adults. GBM starts from a small fraction of poorly differentiated and aggressive cancer stem cells (CSCs) responsible for aberrant proliferation and invasion. Due to extreme tumor heterogeneity, actual therapies provide poor positive outcomes, and cancers usually recur. Therefore, alternative approaches, possibly targeting CSCs, are necessary against GBM. Among emerging therapies, high intensity ultra-short pulsed electric fields (PEFs) are considered extremely promising and our previous results demonstrated the ability of a specific electric pulse protocol to selectively affect medulloblastoma CSCs preserving normal cells. Here, we tested the same exposure protocol to investigate the response of U87 GBM cells and U87-derived neurospheres. By analyzing different in vitro biological endpoints and taking advantage of transcriptomic and bioinformatics analyses, we found that, independent of CSC content, PEF exposure affected cell proliferation and differentially regulated hypoxia, inflammation and P53/cell cycle checkpoints. PEF exposure also significantly reduced the ability to form new neurospheres and inhibited the invasion potential. Importantly, exclusively in U87 neurospheres, PEF exposure changed the expression of stem-ness/differentiation genes. Our results confirm this physical stimulus as a promising treatment to destabilize GBM, opening up the possibility of developing effective PEF-mediated therapies.

Indexed as

Brain NeoplasmsCerebellar NeoplasmsGlioblastomaAdultCell Line, TumorHumansNeoplasm Recurrence, LocalNeoplastic Stem Cellscancer stem cells (CSCs)gliomaneurospherespulsed electric fieldtranscriptomic analysis

Identifiers

PMID35328420
PMCPMC8950115
OpenAlexW4220813984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.